![]() This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Learn more at and follow us on Twitter and LinkedIn.Īurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. as well as international brands, Pedanios, Bidiol and CraftPlant. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. facebook, twitter, linkedin.Īurora is opening the world to cannabis, serving both the medical and consumer markets. Patients can download the free Strainprint App on the Apple Store and Google Play Store.īased in Toronto, Canada, Strainprint ® Technologies is the leading data and analytics technology platform for medical and recreational cannabis use research. Since 2016, Strainprint ® has been providing decision-support research tools and data to cannabis patients, doctors, licensed producers, retailers, industry regulators, academic researchers and pharmaceutical/biotechnology companies across Canada, the U.S., Australia, Israel and New Zealand. With over 2.1 million real-time user-interactions logged against 9,500+ legal and lab-tested cannabis products on the Strainprint ® platform (over 100 million data points), Strainprint ® is also the most extensive real-world evidence (RWE) study on therapeutic cannabis use and its impact on over 300 therapeutic conditions and symptoms - Cannabis Big Data ®! Strainprint data is regularly published in peer-reviewed research journals, providing credibility, plus data-backed insight and formulation guidance for cannabis processors, pharmaceutical and therapeutics manufacturers and consumer packaged goods companies in the cosmetics, food and beverage industries. Strainprint Analytics can be seamlessly integrated with most electronic medical records, seed2sale, and point-of-sale software systems. The Strainprint journal App is free to patients and can be downloaded from both the IOS App Store and Google Play Store. "By working with Strainprint, we can support our patients every step of the way, and further Aurora's promise to prioritize patient well-being and provide the highest quality products." "We take a patient-first approach to cannabis and are proud to provide our patients with programs that improve their lives and their medical cannabis journey," says Mike Jones, SVP of Medical at Aurora Cannabis. All data entered and gathered by the Strainprint App is anonymous and aggregated. Patients can also explore new products, learn more about strains and understand what has helped other patients through the App. ![]() Alongside the advice of a healthcare professional, Aurora patients can use the award-winning Strainprint ® App journal to track their medical cannabis journey by logging their symptoms and consumption habits to better understand which strains, THC and CBD levels, ingestion methods and doses best work for them.
0 Comments
Leave a Reply. |